Representative before the EPO

Employment test 51 - 200 employees
Company dna weickmann and weickmann
operating since 1882
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna weickmann and weickmann patentanwalte postfach 86 08 20
no operation time available
1 office
active in Legal Services

Christian Heubeck has worked on the following 61 EPO patent applications which have been published in the last five years:

EP12190525

Pharmaceutical composition comprising a GLP-1-agonist, an insulin, and methionine

IPC classification:
A61K 9/00, A61K 38/26, A61K 38/28, A61K 47/10, A61K 47/18, A61P 3/10
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11746365

USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS

IPC classification:
A61K 31/275, A61K 45/06, A61P 25/02, A61P 25/28
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11160032

Purification of triphosphorylated oligonucleotides using capture tags

IPC classification:
C07H 21/02
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP13156104

Methods and compositions for targeted integration

IPC classification:
C12N 15/86, C12N 15/867
Applicant:
Sangamo BioSciences, Inc.
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP11757275

ERBB3 BINDING ANTIBODY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32
Agent:
Patronus IP Ganahl Naefe GbR
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP11162877

Gpr177 as target and marker in tumors

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11189740

Selective imaging of actin in live native cells

IPC classification:
A61K 47/48, A61K 49/00, A61K 51/08, C07K 5/02, C07K 5/06, C07K 5/08
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Applicant:
Technische Universität Dortmund
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11173916

Method for producing an ammonium or alkali metal peroxodisulfate in a non-separated electrolysis area

IPC classification:
C25B 1/28
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710950

PURIFICATION OF TRIPHOSPHORYLATED OLIGONUCLEOTIDES USING CAPTURE TAGS

IPC classification:
C07H 21/02
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Armin Bohmann, Kanzlei bohmann
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP13151840

Wheat plants having increased resistance to imidazolinone herbicides

IPC classification:
A01H 1/00, A01H 5/00, C12N 15/29, C12N 15/82
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13173978

Use of 5-fluorocytosine and its derivatives as fungicides

IPC classification:
A01N 43/54, A01N 47/24, A01P 3/00
Applicant:
Dow AgroSciences LLC
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11181760

Method to purify and concentrate prions from complex mixtures such as plasma into a target solution

IPC classification:
C07K 1/18, G01N 33/68
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14152800

Methods and compositions for treating trinucleotide repeat disorders

IPC classification:
A61K 38/00, A61K 38/16, A61K 48/00, A61P 25/28, C07K 14/47, C12N 15/90
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12828871

GLYCOSYLATED POLYPEPTIDE AND DRUG COMPOSITION CONTAINING SAID POLYPEPTIDE

IPC classification:
A61K 38/00, A61K 47/48, A61P 1/00, A61P 1/04, A61P 1/12, A61P 3/10, A61P 5/02, A61P 19/02, A61P 25/04, A61P 25/28, A61P 27/02, A61P 27/06, A61P 27/12, A61P 29/00, A61P 35/00, A61P 43/00, C07K 2/00, C07K 14/655, C07K 19/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12828271

GLYCOSYLATED POLYPEPTIDE AND DRUG COMPOSITION CONTAINING SAID POLYPEPTIDE

IPC classification:
A61K 38/00, A61K 47/48, A61P 1/00, A61P 1/04, A61P 1/12, A61P 3/10, A61P 5/02, A61P 19/02, A61P 25/04, A61P 25/28, A61P 27/02, A61P 27/06, A61P 27/12, A61P 29/00, A61P 35/00, A61P 43/00, C07K 2/00, C07K 14/655, C07K 19/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14163013

Methods and compositions for gene inactivation

IPC classification:
C07K 14/715, C12N 15/113
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12839684

ERYTHROPOIETIN PRODUCTION-PROMOTING AGENT

IPC classification:
A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/26, A61K 33/30, A61P 7/06, A61P 13/12, A61P 43/00
Applicant:
Tohoku University
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12839430

IMPROVING / PROPHYLACTIC AGENT FOR CHRONIC KIDNEY DISEASE

IPC classification:
A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/24, A61K 33/26, A61K 33/28, A61K 33/30, A61K 33/34, A61P 13/12, A61P 43/00
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11863061

WORK HOOD

IPC classification:
A42B 1/04, A42B 1/24
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12186444

Novel RIG-I ligands and methods for producing them

IPC classification:
C07H 21/02
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11767977

METHODS FOR SEMI-SYNTHETICALLY PRODUCING HIGHLY PURE MINICIRCLE DNA VECTORS FROM PLASMIDS

IPC classification:
C12N 15/64, C12N 15/79
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12854923

AGENT FOR PREVENTING AND/OR TREATING VEISALGIA

IPC classification:
A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/14, A61K 33/24, A61K 33/26, A61K 33/30, A61K 33/34, A61P 3/00
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12176507

Activated HER3 as a marker for predicting therapeutic efficacy

IPC classification:
G01N 33/574
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10844709

PROCESS FOR PRODUCTION OF COMPOSITE FINE PARTICLES WITH HETEROGENEOUS SURFACES

IPC classification:
B01J 2/00, C08F 2/02, C08F 257/02, C08F 265/00, C08J 3/12, G02B 26/02
Applicant:
Sekisui Chemical Co., Ltd.
Applicant:
Niigata University
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP14175292

TNFSF single chain molecules

IPC classification:
A61K 38/17, C07K 14/525, C07K 14/705, C12N 15/11, C12N 15/62
Applicant:
Apogenix AG
Applicant:
Apogenix GmbH
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14170013

Methods and compositions for targeted single-stranded cleavage and targeted integration

IPC classification:
C12P 21/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12172594

Method for the capture or removal of amyloidogenic proteins

IPC classification:
B01J 20/282, C07K 14/47, G01N 33/68
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704961

COMBINATION OF HB-EGF BINDING PROTEIN AND EGFR INHIBITOR

IPC classification:
A61K 31/517, A61K 39/395, C07K 16/22, C07K 16/28, C07K 16/30, C07K 16/40
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705987

HER3 INHIBITOR FOR MODULATING RADIOSENSITIVITY

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/32
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14177478

Ruthenium and Osmium Heterocyclic Carbene Metathesis Catalysts

IPC classification:
C07F 15/00, C08F 4/00
Applicant:
Bergen Teknologioverføring AS
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13769902

HETEROCYCLIC COMPOUND

IPC classification:
A61K 31/506, A61K 31/5377, A61K 31/541, A61P 1/04, A61P 17/06, A61P 19/02, A61P 25/00, A61P 37/02, A61P 43/00, C07D 401/04, C07D 401/14, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13772589

METHODS AND SYSTEMS FOR CUSTOMIZING COCHLEAR IMPLANT STIMULATION AND APPLICATIONS OF SAME

IPC classification:
A61F 2/02, A61F 2/18, A61F 2/76
Applicant:
Vanderbilt University
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13742057

COMBINATORIC ENCODING METHODS FOR MICROARRAYS

IPC classification:
C12Q 1/68
Applicant:
National University of Singapore
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP13793390

A MICROPARTICLE ASSEMBLY

IPC classification:
G01N 33/533, G01N 33/542
Applicant:
National University of Singapore
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13796783

METHOD FOR ASSESSING ENDOMETRIOSIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/48
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12739875

INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT OF SAME

IPC classification:
A61K 31/404, A61K 31/41, A61K 31/427, A61K 31/4439, A61K 31/444, A61K 31/506, A61K 45/00, A61P 13/02, A61P 13/10, A61P 43/00, C07D 209/18, C07D 401/06, C07D 401/14, C07D 403/10, C07D 405/06, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/06, C07D 419/14
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11754126

TRIGGERED CARGO RELEASE FROM NANOPARTICLE STABILIZED LIPOSOMES

IPC classification:
A01N 25/26, A01N 25/28, A61K 9/127, A61K 9/51
Applicant:
The Regents of the University of California
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13840884

PROCESS FOR PRODUCING SOLID PARTICLES

IPC classification:
A61K 9/14, A61K 31/192
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13857593

GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID COMPOUND OR SALT THEREOF

IPC classification:
A61K 38/00, A61K 47/48, A61P 31/00, A61P 35/00, C07K 4/12, C08B 37/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13859242

SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME

IPC classification:
A61K 39/00, A61K 47/26, A61K 47/36, A61K 47/48, C07K 1/06
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP15162381

AXL ANTIBODIES

IPC classification:
A61K 31/282, A61K 31/704, A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12739597

INDOLE DERIVATIVE, AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

IPC classification:
A61K 31/404, A61K 31/4439, A61K 31/444, A61K 45/00, A61P 13/02, A61P 13/10, A61P 43/00, C07D 209/08, C07D 401/06, C07D 401/14, C07D 405/06, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863709

RECOMBINANT PROTEIN

IPC classification:
A61K 38/18, A61P 7/06, C07K 14/505, C07K 19/00, C12N 5/10, C12N 15/62
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15170809

IMMUNOGENIC COMPOSITION AND USES THEREOF

IPC classification:
A61K 31/13, A61K 31/23, A61K 38/03, A61K 38/38, A61K 39/00, A61P 37/04
Applicant:
University of Melbourne
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14751813

METHOD FOR PRODUCING A PLURALITY OF TEETH FROM ONE ISOLATED TOOTH GERM

IPC classification:
A61K 6/02, A61L 27/00, C12N 5/073
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14706543

CAIX STRATIFICATION BASED CANCER TREATMENT

IPC classification:
A61K 39/395, A61P 35/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14773826

HETEROCYCLIC COMPOUND

IPC classification:
A61K 31/437, A61K 31/438, A61K 31/4545, A61K 31/496, A61K 31/4985, A61K 31/5377, A61K 31/541, A61K 31/553, A61P 1/04, A61P 17/00, A61P 17/06, A61P 19/08, A61P 25/00, A61P 29/00, A61P 37/02, A61P 37/06, A61P 43/00, C07D 471/04, C07D 519/00
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15181215

RECEPTORS OF RSPO2 AND RSPO3

IPC classification:
A61K 39/00, G01N 33/50, G01N 33/68
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP14720964

METHOD OF DIAGNOSING CANCER

IPC classification:
G01N 33/574
Applicant:
Apogenix AG
Applicant:
Apogenix GmbH
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15190671

RSPONDINS AS MODULATORS OF ANGIOGENESIS AND VASCULOGENESIS

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
GRANT OF PATENT INTENDED
EP14820598

METAL FOIL FOR ELECTROMAGNETIC SHIELDING, ELECTROMAGNETIC SHIELDING MEMBER, AND SHIELDED CABLE

IPC classification:
B32B 15/08, C23C 30/00, C25D 5/10, C25D 5/50, C25D 7/06, H01B 5/02, H01B 5/14, H01B 7/17, H05K 9/00
Applicant:
JX Nippon Mining & Metals Corporation
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14814295

MEDICINAL COMPOSITION FOR PROMOTING SYNTHESIS OF PROTOPORPHYRIN IX

IPC classification:
A61K 31/19, A61K 31/194, A61K 31/198, A61K 31/375, A61K 33/40, A61K 41/00, A61K 45/00, A61P 31/04, A61P 43/00
Applicant:
Osaka City University
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14820189

ELECTROMAGNETIC WAVE SHIELD-USE METAL FOIL, ELECTROMAGNETIC WAVE SHIELD MATERIAL AND SHIELD CABLE

IPC classification:
B32B 9/00, C22C 13/00, C22C 19/03, C23C 8/12, C23C 14/06, C23C 28/00, C25D 5/12, C25D 5/50, H01B 7/17, H05K 9/00
Applicant:
JX Nippon Mining & Metals Corporation
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11752253

NOVEL OLEFIN METATHESIS CATALYSTS

IPC classification:
B01J 31/16, B01J 31/18, B01J 31/22, C07F 15/00
Applicant:
Bergen Teknologioverføring AS
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12197774

2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4- pyrimidinecarboxylates and their use as herbicides

IPC classification:
A01N 43/54, C07D 239/42
Applicant:
Dow AgroSciences LLC
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14854505

DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING

IPC classification:
C12N 15/64, C12N 15/85
Applicant:
Sangamo BioSciences, Inc.
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP16150412

TNF SUPERFAMILY COLLECTIN FUSION PROTEINS

IPC classification:
A61K 38/19, C07K 14/42, C07K 14/47, C07K 14/525, C12N 5/10, C12N 15/28, C12N 15/62
Applicant:
Apogenix AG
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP15161647

DIAGNOSIS AND TREATMENT OF LOW GRADE GLIOMAS

IPC classification:
G01N 33/574
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Ludwig-Maximilians-Universität München
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP15168152

COMBINATION OF FGFR4-INHIBITOR AND BILE ACID SEQUESTRANT

IPC classification:
A61K 31/7088, A61K 31/785, A61K 31/787, A61K 38/02, A61K 38/16, A61K 39/00, A61K 39/395, A61K 45/06, A61P 3/04, A61P 3/10, A61P 9/00, A61P 9/12, A61P 13/12, A61P 21/00, A61P 35/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP15176276

IMPROVED OLEFIN METATHESIS CATALYSTS

IPC classification:
C07F 15/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION WITHDRAWN
EP10807590

RECEPTORS OF RSPO2 AND RSPO3

IPC classification:
G01N 33/68
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature